Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Pancras C.W. Hogendoorn(Vrije Universiteit Brussel), D. Vanel(Institut Gustave Roussy), Angelo Paolo Dei Tos(University of Padua), Hans Gelderblom(Leiden University Medical Center), A. Bassim Hassan(Kassala University), Jeremy Whelan(University College London Hospitals NHS Foundation Trust), Nick Athanasou, R. J. Grimer(Royal Orthopaedic Hospital), S. Ferrari(Fondazione IRCCS Istituto Nazionale dei Tumori), Kirsten Sundby Hall(Oslo University Hospital), A. H. M. Taminiau, L. B. Rozeman(Université Claude Bernard Lyon 1), Michael Paulussen, Heribert Jürgens(University Hospital Münster), S. Bielack(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 718
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Cremophor EL
|European Journal of Cancer|2001|1.6k
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.6k